Stacy Ellen Hatcher, BS; Emmanuelle Waubant, MD, PhD; Bardia Nourbakhsh, MD; et al.
free access
JAMA Neurol. 2016;73(7):790-794. doi:10.1001/jamaneurol.2016.0826
This case series describes rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment.
Noriko Isobe, MD, PhD; Anisha Keshavan, BSc; Pierre-Antoine Gourraud, PhD, MPH; et al.
free access
JAMA Neurol. 2016;73(7):795-802. doi:10.1001/jamaneurol.2016.0980
This case-control study examines associations between cumulative HLA genetic risk burden and clinical and MRI-based phenotypes in patients with multiple sclerosis.
Feng-Chiao Su, PhD; Stephen A. Goutman, MD; Sergey Chernyak, PhD; et al.
free access
JAMA Neurol. 2016;73(7):803-811. doi:10.1001/jamaneurol.2016.0594
This case-control study evaluates the association of exposures to environmental toxins with the odds of developing amyotrophic lateral sclerosis.
-
Editorial
The Role of Environmental Toxins in Amyotrophic Lateral Sclerosis Risk
Jacquelyn J. Cragg, PhD; Merit E. Cudkowicz, MD, FRCPC; Marc G. Weisskopf, PhD
JAMA Neurol
Isabella Fogh, PhD; Kuang Lin, PhD; Cinzia Tiloca, PhD; et al.
free access
JAMA Neurol. 2016;73(7):812-820. doi:10.1001/jamaneurol.2016.1114
This genome-wide association study investigates genetic loci associated with survival in an international population of patients with amytrophic lateral sclerosis.
-
Editorial
Variability in Amyotrophic Lateral Sclerosis
Nathan P. Staff, MD, PhD
JAMA Neurol
Chad G. Rusthoven, MD; Matthew Koshy, MD; David J. Sher, MD; et al.
free access
JAMA Neurol. 2016;73(7):821-828. doi:10.1001/jamaneurol.2016.0839
This cohort study examines data on elderly patients with glioblastoma from the National Cancer Database to compare the association of overall survival with combined-modality therapy including radiotherapy and chemotherapy, radiotherapy alone, and chemotherapy alone.
-
Editorial
The Age Factor in the Treatment of Glioblastoma
Stephen W. Clark, MD, PhD
JAMA Neurol
Kimberly N. Grelli, MD; Melissa C. Gindville, MS; C. Haley Walker, BA; et al.
free access
JAMA Neurol. 2016;73(7):829-835. doi:10.1001/jamaneurol.2016.0992
This cohort study aims to determine the prevalence of abnormal blood pressure, blood glucose levels, and temperature in pediatric patients with acute arterial ischemic stroke and to explore any association between these measures and neurological outcome.
Ghayda M. Mirzaa, MD; Catarina D. Campbell, PhD; Nadia Solovieff, PhD; et al.
free access
JAMA Neurol. 2016;73(7):836-845. doi:10.1001/jamaneurol.2016.0363
This study uses whole-exome and targeted squencing to identify constitutional and mosaic mutations of MTOR associated with focal cortical dysplasia, hemimegalencephaly, and diffuse megalencephaly.
Stephanie Kielb, MS; Amanda Cook, MA; Christina Wieneke, BA; et al.
free access
JAMA Neurol. 2016;73(7):846-852. doi:10.1001/jamaneurol.2016.0880
This study of clinical and autopsy data examines the association of memory problems with primary progressive aphasia on the basis of autopsy-confirmed neuropathologic diagnoses of frontotemporal lobar degeneration vs Alzheimer disease.
Anastasia Zekeridou, MD; Andrew McKeon, MD; Vanda A. Lennon, MD, PhD
free access
JAMA Neurol. 2016;73(7):853-859. doi:10.1001/jamaneurol.2016.0603
This cross-sectional study reports the proportion of patients with thymoma who had potentially pathogenic neural synaptic autoantibodies.
Noah A. Kolb, MD; A. Gordon Smith, MD; J. Robinson Singleton, MD; et al.
free access
JAMA Neurol. 2016;73(7):860-866. doi:10.1001/jamaneurol.2016.0383
This study explores the association between the symptoms of chemotherapy-induced peripheral neuropathy and the risk of falls for patients receiving neurotoxic chemotherapy.